[GeSIDA quality care indicators associated with mortality and hospital admission for the care of persons infected by HIV/AIDS].
BACKGROUND
In 2010, the AIDS Study Group (Grupo de Estudio del SIDA [GESIDA]) developed 66 quality care indicators. The aim of this study is to determine which of these indicators are associated with mortality and hospital admission, and to perform a preliminary assessment of a prediction rule for mortality and hospital admission in patients on treatment and follow-up.


METHODS
A retrospective cohort study was conducted in the Hospital Universitario Son Espases (Palma de Mallorca, Spain). Eligible participants were patients with human immunodeficiency syndrome≥18 years old who began follow-up in the Infectious Disease Section between 1 January 2000 and 31 December 2012. A descriptive analysis was performed to evaluate anthropometric variables, and a logistic regression analysis to assess the association between GESIDA indicators and mortality/admission. The mortality probability model was built using logistic regression.


RESULTS
A total of 1,944 adults were eligible (median age: 37 years old, 78.8% male). In the multivariate analysis, the quality of care indicators associated with mortality in the follow-up patient group were the items 7, 16 and 20, and in the group of patients on treatment were 7, 16, 20, 35, and 38. The quality of care indicators associated with hospital admissions in the follow-up patients group were the same as those in the mortality analysis, plus number 31. In the treatment group the associated quality of care indicators were items 7, 16, 20, 35, 38, and 40.


CONCLUSIONS
Some GeSIDA quality of care indicators were associated with mortality and/or hospital admissions. These indicators are associated with delayed diagnosis, regular monitoring, prevention of infections, and control of comorbidities.
Hospital Universitario Son Espases, Palma de Mallorca, España. Electronic address: elena.delgado@ssib.es.
Elena
E
Delgado-Mejía
Hospital Universitario Son Espases, Palma de Mallorca, España.
Guillem
G
Frontera-Juan
Hospital Universitario Son Espases, Palma de Mallorca, España.
Javier
J
Murillas-Angoiti
Hospital Universitario Son Espases, Palma de Mallorca, España.
Antoni Abdon
AA
Campins-Roselló
Hospital Universitario Son Espases, Palma de Mallorca, España.
Leire
L
Gil-Alonso
Hospital Universitario Son Espases, Palma de Mallorca, España.
María
M
Peñaranda-Vera
Hospital Universitario Son Espases, Palma de Mallorca, España.
María Angels
MA
Ribas Del Blanco
Hospital Universitario Son Espases, Palma de Mallorca, España.
María Luisa
ML
Martín-Pena
Hospital Universitario Son Espases, Palma de Mallorca, España.
Melchor
M
Riera-Jaume
D000163:Acquired Immunodeficiency Syndrome / Q000401:mortality / Q000628:therapy; D000328:Adult; D015331:Cohort Studies; D005260:Female; D015658:HIV Infections / Q000401:mortality* / Q000628:therapy*; D006801:Humans; D008297:Male; D010343:Patient Admission; D019984:Quality Indicators, Health Care; D012189:Retrospective Studies
Acquired immune deficiency syndrome; Admission; Human immunodeficiency syndrome care indicators; Human immunodeficiency virus; Indicadores de calidad; Ingreso; Mortalidad; Mortality; Sida; Virus de la inmunodeficiencia humana